FROM:
Chiropractic & Manual Therapies 2024 (May 14); 32 (1): 16 ~ FULL TEXT
Sasha L Aspinall • Casper Nim • Jan Hartvigsen • Chad E Cook
Eva Skillgate • Steven Vogel • David Hohenschurz-Schmidt
Martin Underwood • Sidney M Rubinstein
School of Allied Health,
Murdoch University,
Perth, Australia
Background: Research waste is defined as research outcomes with no or minimal societal benefits. It is a widespread problem in the healthcare field.
Four primary sources of research waste have been defined:
(1) irrelevant or low priority research questions,
(2) poor design or methodology,
(3) lack of publication, and
(4) biased or inadequate reporting.
This commentary, which was developed by a multidisciplinary group of researchers with spinal manipulative therapy (SMT) research expertise, discusses waste in SMT research and provides suggestions to improve future research.
Main text: This commentary examines common sources of waste in SMT research, focusing on design and methodological issues, by drawing on prior research and examples from clinical and mechanistic SMT studies. Clinical research is dominated by small studies and studies with a high risk of bias. This problem is compounded by systematic reviews that pool heterogenous data from varying populations, settings, and application of SMT. Research focusing on the mechanisms of SMT often fails to address the clinical relevance of mechanisms, relies on very short follow-up periods, and has inadequate control for contextual factors.
Conclusions: This call to action is directed to researchers in the field of SMT. It is critical that the SMT research community act to improve the way research is designed, conducted, and disseminated. We present specific key action points and resources, which should enhance the quality and usefulness of future SMT research.
Keywords: Methodology; Research waste; Spinal manipulative therapy.
From the FULL TEXT Article:
Background
Globally in 2010, US$240 billion was spent on health research [1], most commonly on basic science and less on applied or clinical research. In 2009, Chalmers and Glasziou [2] estimated that 85% of funding for health research was wasted and defined four primary sources of research waste:
(1)
irrelevant or low priority research questions,
(2)
poor design or methodology,
(3)
lack of publication, and
(4)
biased or inadequate reporting.
Disappointingly, they concluded in 2018 that while various initiatives had emerged to reduce waste and increase value, research waste remains a major problem. [3] Systematic reviews also contribute to this problem, with potentially few being both good quality and informative. [4] In recent years, the issue of research waste has been compounded by so-called ‘predatory’ journals with questionable or even absent peer-review practices, providing a platform for poorer quality research to be published under the guise of being adequately peer-reviewed. [5, 6]
Since the issue of wasted healthcare research first received widespread attention in 1994 [7], initiatives to improve the quality and reporting of research have been introduced, such as the first CONSORT statement in 1996 for randomised controlled trials (RCTs) [8] and the first PRISMA statement in 2009 for systematic reviews. [9] Furthermore, since 2005 the International Committee of Medical Journal Editors (ICMJE) requires that clinical studies pre-register their protocol for two main purposes:
(1)
to limit publication bias, and
(2)
to prevent selective outcome reporting. [40]
Most reputable journals, including those that commonly publish manual and physical therapy research [11, 12], state that they require clinical studies and systematic reviews to be pre-registered and to follow reporting guidelines such as the CONSORT and PRISMA Statements. However, enforcement of this remains unclear. For example, it appears common that articles lack a priori versions of trial protocols and statistical analysis plans even in high impact medical journals. [13] A 2020 review of reporting quality in manual therapy trials found that while reporting improved in some areas after implementation of the CONSORT Statement for non-pharmacologic interventions, it overall remained poor. [14]
According to the World Health Organization (WHO), less than 3% of the grants funded by agencies reporting to the WHO in 2020 were awarded for research in the field of musculoskeletal disorders. Of those, only 36 (0.06% in total) addressed back pain [15] despite back pain being the number one cause of disease burden [16], defined as years lived with disability globally. A 2023 European Union (EU) report lists musculoskeletal pain as one of 12 main groups of proposed high-burden under-researched conditions, and states that the EU spends only 0.39% of health research funding on low back pain. [17] This highlights a critical issue for musculoskeletal researchers. While more resources should undoubtedly be allocated toward musculoskeletal research, we cannot afford to waste the limited resources we do receive!
Various interventions exist for the treatment of spinal pain, including spinal manipulative therapy (SMT). SMT is defined as manual therapy techniques that include high-velocity low-amplitude (HVLA) or thrust manipulation as well as low-velocity low-amplitude techniques such as mobilisation (or non-thrust manipulation). [18] It is used by a wide range of health professionals, including chiropractors, physiotherapists/physical therapists, osteopaths, and naprapaths, for a variety of conditions, most frequently back and neck pain. [18] SMT is commonly recommended as a component of multi-modal care or second-line treatment for back and neck pain in international guidelines. [19, 20] However, the recommendations are typically based on low- or very low-certainty evidence, which appears to stem from a range of inadequacies in SMT research. Additionally, the underlying therapeutic mechanisms of SMT are inadequately understood [21, 22], and research is complicated by the multifactorial and poorly understood nature of spinal pain. [23] In short, there is a need for higher-quality research addressing clinical and mechanistic aspects of SMT [22, 24]; however, this research needs to be strategically focused so it addresses relevant research questions and identified knowledge gaps, and must be carried out and reported in such a manner that it truly contributes to the evidence base and not to the pile of research waste.
A multidisciplinary group of researchers with SMT and clinical experience have written this commentary to draw attention to the need for more high-quality research into SMT, primarily focusing on study design and methodology. We first discuss key issues in clinical then mechanistic SMT research. We then provide eight key action points and highlight various resources which we consider, if widely implemented, will reduce SMT research waste.
Main text
Clinical research
Trials investigating clinical effects of SMT are abundant, as are systematic reviews of these, especially for spinal pain. For example, a review protocol published in 2023 identified 85 systematic reviews which investigated the effects of SMT on patient-reported outcomes (including 442 trials). [25] Despite the many papers, little progress has been made in identifying when SMT is likely to be beneficial and it remains unclear how SMT should be applied. The problem is compounded by systematic reviews offering conflicting conclusions often based upon evidence of low certainty, much of which can be ascribed to trials with a small sample size or high risk of bias.
In clinical SMT trials, there are often concerns with both internal and external validity. Regarding internal validity, reviews have identified frequent sources of potential bias. This includes inadequate randomisation and allocation concealment [26–31], which can introduce allocation bias and confounding through systematic differences in prognostic factors between groups. In addition, missing outcome data or loss to follow-up, especially if unbalanced between groups, is a common concern. [26, 27, 29, 30] Researchers should also be thoughtful about using appropriate outcome measures that are both valid and reliable. Potential bias in the reporting of results is also common [26, 27, 31, 32], where reporting may be influenced by knowledge of the results, such as omitting certain results or changing the primary outcome. Often these biases are difficult to assess due to poor reporting, resulting in higher risk of bias scores in reviews and, therefore, contributing to uncertainty. In particular, assessing reporting bias typically requires access to a detailed pre-registered statistical analysis plan, which is frequently absent.
Unclear or lack of blinding of participants, therapists, outcome assessors, and data analysers is also common. [26–31] This can lead to bias where knowledge of the intervention allocation leads to differences in participant or researcher behaviour (performance bias), or differences in how participants or researchers assess the outcome of interest (detection bias). We acknowledge that effective blinding of participants and therapists is particularly challenging for manual therapies. [33] Participant blinding is not always essential for effectiveness trials which assess real-world effects, while it is important for efficacy and mechanistic trials. In studies that do attempt participant blinding, few specifically assess and report on blinding success [32, 33], making it difficult to know whether expectations about outcomes were balanced between groups. Regardless, blinding of outcome assessors and data analysers is often very feasible and should be implemented.
As for external validity, descriptions of SMT tend to lack details (e.g., SMT target, intensity/dosage, and whether/how interventions were tailored to individuals). [34] Such poor reporting makes it challenging for stakeholders to decide how applicable trial results are to their target setting and population. It also makes comparisons between studies and replication more difficult. Another issue affecting external validity is that procedures and interventions in SMT trials may poorly reflect how SMT is typically delivered in clinical practice. Researchers should carefully consider whether their research questions and design call for more experimental/controlled interventions or more pragmatic interventions.
Related to this is treatment fidelity, which is the degree to which an intervention was implemented and delivered in a study as intended. [35] Poor adherence to the intervention plan and poor performance of SMT affects both external and internal validity. [36] Data regarding fidelity are currently limited, especially for SMT, but fidelity is often not reported on in related fields [37] and health researchers appear to have poor knowledge or understanding of the concept. [37] In 2016, Karas and Plankis [39] made recommendations about how treatment fidelity can be implemented in manual therapy research. Methods to this end include standardising treatment dosages (e.g., time, repetitions, grade, force), as well as interactions between researchers and participants. [39] Strategies to enhance and monitor adherence can include the use of treatment manuals, specific therapist training, checklists, and observation of interventions. [39] As an emerging topic in ensuring methodological quality, future SMT researchers are encouraged to consider methods to enhance treatment fidelity and report on those explicitly.
A 2014 review reported a trend of improvement in the methodological quality of SMT studies, though trials remained small.
[40] Despite this, authors of the 2019 updated Cochrane review on the effects of SMT for chronic low back pain [26] identified five new small pragmatic studies with a high risk of bias. [41–45] It was unclear in all five of these RCTs whether the treatment allocation was conducted properly, and only two had a registered protocol. [41, 44] Small studies may be underpowered, especially for secondary outcome measures, and this increases the risk of both type I and type II errors. There are also examples of small pilot studies [46] that make conclusions about SMT treatment effects. This may reflect misconceptions about the purpose of pilot studies [47] which are intended to assess the feasibility of conducting larger trials and should not be used to estimate treatment efficacy or effectiveness. These issues would suggest that we do not learn from past mistakes, or perhaps that messages about enhancing methodological quality have not been spread sufficiently.
While it is strongly encouraged that the results of all studies are published [2], poorer quality trials can confuse clinicians and patients and contribute to uncertainty in systematic reviews, rather than strengthening the evidence base. Poor quality trials also raise ethical concerns – it can be considered wasteful and inappropriate to expose participants to the risks and burden of participation when the results of that research might not be valuable or particularly informative, for example due to serious methodological flaws or particularly small sample sizes. To serve all the above needs, the solution is to improve the quality of trials being conducted in the first place, then to ensure they are published and reported appropriately.
Relatedly, it is important that clinicians and authors of case reports recognise that they can be valuable in specific circumstances, e.g., rare conditions or completely unexpected outcomes, but they are typically insufficient to inform treatment and policy decisions. Case reports should not be presented as evidence of SMT’s effect on particular outcomes.
Unfortunately, waste is not just limited to clinical trials but also occurs in systematic reviews and meta-analyses of SMT. One significant issue is the pooling of studies with highly heterogenous clinical populations (e.g., acute and chronic spine pain, radiculopathy, dysmenorrhea, and others [58]), different types of manual therapies [31], or different intervention dosage and frequency. [31] Pooling data for such varied conditions and interventions is problematic given the diverse aetiologies, treatment characteristics, and proposed mechanisms that may influence clinical outcomes. Furthermore, the type of meta-analysis should be appropriate; for example, the use of fixed-effects meta-analyses [31] may often be inappropriate in SMT research since it assumes minimal heterogeneity between studies. [48] Hence, issues around heterogeneity and appropriate statistical tests in reviews should be carefully considered to ensure reviews are informative for clinicians and other researchers. It is also important to recognise that the certainty of findings from a systematic review are directly influenced by the quality of the included studies, and SMT reviews frequently report low certainty due to the low quality of included studies. [26, 27, 30]
Mechanistic research
At present, the frameworks surrounding how SMT works are highly theoretical, highlighting our lack of understanding of SMT mechanisms. Many biomechanical and neurophysiological mechanisms have been investigated, including joint cavitations, joint forces, spinal stiffness, muscle activity, pain sensitivity, inflammatory markers, cortical activity, and autonomic activity. Reviews have highlighted the many knowledge gaps and weaknesses in the literature.
[21, 22, 49–51] These include short-term outcomes, a lack of translational research and demonstrated clinical relevance, and inadequate control for contextual factors.
The typical translational workflow of research, advancing from basic science with animal or laboratory models to humans, then clinical populations and finally real-world settings [52], is often not followed in mechanistic SMT research. For example, many human studies assessing pain inhibition using quantitative sensory tests have been summarised in multiple systematic reviews [53–57], yet few animal studies directly assess painful stimuli after joint manipulation and attempt to illustrate related neurophysiological pathways. [21, 50, 58] There is only one study in a pragmatic setting involving more typical clinical care. [59] Therefore, we can observe differences following SMT but, since there are few studies in the early and later stages of the translational research workflow, we do not know exactly what physiological mechanism/s drive this change and whether it is related specifically to SMT.
Relatedly, research often fails to bridge the gap between mechanisms and their clinical relevance.
[21, 22, 49, 51] This is an important step in determining the significance of an observed biomechanical or neurophysiological change, and therefore the value of continuing to research it. This can be explored in various ways, including testing mechanisms in clinical populations and clinical settings, and correlating biomechanical or neurophysiological outcomes with clinical outcomes. Returning to the example of quantitative sensory testing research, several recent studies have found that changes in pressure pain detection threshold after SMT may not correlate with patients’ pain intensity or self-reported improvement [59–61], suggesting that this particular outcome may have limited clinical relevance in our pursuit of understanding specific effects of SMT.
Mediation, moderation, and time-lagged analyses all offer more advanced approaches to studying the clinical relevance of mechanisms, allowing causal inferences to be made. These methods have a long history of use in psychology [62–64], but few studies have used them to elucidate SMT mechanisms. [65] A mediator is a variable measured during treatment that affects (or mediates) the response to treatment. [66] In contrast, a moderator variable is a baseline characteristic that affects response to treatment. [66] These are both distinct from predictors, which are baseline variables that predict outcome independent of any treatment effect. Time-lagged analyses use longitudinal data to explore how the relationships between variables may change over time.
[67] Simplistically, these types of analysis could help identify mechanisms that influence clinical outcomes, or that precede and predict clinical outcomes.
Mechanistic studies are often focused on extremely short time frames compared to clinical trials; a common design is to measure an outcome before and almost immediately after a single-session intervention. For example, studies have observed immediate changes in various serum biomarkers [68, 69] and neurological activity.
[70, 71] Numerous reviews have called for longer-term outcome assessment in mechanistic SMT research. [49, 72–74] Short-term outcome studies can be informative, especially to look for early indications of change, and are relatively easy to conduct (important for under-resourced researchers). However, they can also severely limit the usefulness of findings given that changes may be highly transient and their relevance to clinical outcomes cannot be assumed. If the mechanism of interest appears to be relevant, such short-term studies should be complemented with more pragmatic studies that investigate longer time frames and clinical relevance.
Many mechanistic SMT studies on humans do not adequately account for contextual factors, including participant expectations. [21, 49] For example, some studies use control interventions of passive joint movement
[75, 76] or touch without attempting to blind participants [77] or are conducted on likely non-naďve healthcare students. [78–80] Control interventions in efficacy or mechanistic trials (also known as ‘sham’ controls) that do not attempt to mimic SMT, such as detuned ultrasound, have also been criticised. [33] Such approaches likely result in unequal participant expectations and differences in contextual factors. Given that context-dependent effects can produce wide-ranging neurophysiological changes and clinical effects [81–84], this makes it difficult to attribute observed changes as specific effects of SMT. While there are inherent challenges to this in non-pharmacological interventions, high-quality control interventions to balance expectancy effects and attempts to blind participants are important if we are to understand whether mechanistic (or clinical) responses to SMT are related to the intervention itself or to contextual factors surrounding the delivery of SMT. [85] However, such control interventions are not always feasible or appropriate depending on the trial design and research questions.
Where to next
Given the limited resources and funding opportunities available for SMT research globally and across professions, it is critical that the SMT research community act to enhance the way our research is designed, conducted, and disseminated. This stands to benefit the principal stakeholders in SMT research: clinicians and patients. Adhering to best practice principles for research conduct and reporting is critical, and there are an increasing number of resources specific to studies of musculoskeletal pain, manual therapies, and SMT to support this. Development of methodological guidelines or tools specific to SMT could also advance this field.
There is also a need to collaborate. Working with researchers with diverse skills and from various disciplines and institutions provides wide-ranging benefits, such as improved possibilities to acquire funding, sharing of expertise and resources, more innovative and flexible thinking, and higher impact. [86–88] Collaboration can also mean involving clinicians and/or patients in the design and conduct of studies, which helps ensure research questions and methodologies are relevant and impactful to stakeholders. [89, 90]
Nonetheless, we acknowledge there are barriers to achieving this goal. Perhaps most important is the limited funding available for musculoskeletal research. For SMT specifically, many studies are conducted with no or minimal funding, or as research student projects. This hampers efforts to conduct large and robust trials, limiting access to resources and methodological expertise. Building effective inter-disciplinary collaborations and teams that can be competitive in seeking funding is a critical step in addressing this issue. Supporting future SMT researchers is also important, and at times this can lead to conflict between the needs of the novice or early career researcher and the desire to conduct highly powered and impactful research. A key aspect of early career SMT researcher experiences should focus on the development of knowledge, skills, and values required to conduct high-quality research. This includes instilling a deep commitment to academic rigour, integrity, and transparency. For research students wishing to develop skills in SMT trials, it is important that adequate resources and supports are available to ensure the trials are conducted rigorously. This might mean seeking out well-funded teams, especially for clinical research. Crucially, future SMT researchers need the training and support to obtain competitively awarded research funding.
Figure 1
Table 1
|
Despite the barriers, the problem of waste in SMT research is largely avoidable. We call on SMT researchers, supervisors, and funding bodies across all professions to prioritise high-quality research through appropriate research questions, design and methodology, publication, and reporting. In Figure 1 we summarise eight key action points arising from this paper. We also highlight resources intended to improve the quality of research in Table 1.
In support of this Call to Action, the authors of this commentary are planning to develop a series of papers addressing specific issues relating to waste in SMT research. While numerous prior papers have tackled this issue in the biomedical field generally [91–95], future papers will take a focused view on specific problems and practical solutions in our field of SMT research.
Conclusion
This call to action is directed to researchers in the field of SMT. It is critical that the SMT research community act to improve the way research is designed, conducted, and disseminated in order to enhance the usefulness of SMT research for clinicians and patients. In pursuit of this goal, we present eight key action points and various resources that are relevant for SMT research.
Abbreviations
HVLA = High-velocity low-amplitude
RCT = Randomised controlled trial
SMT = Spinal manipulative therapy
Author contributions
JH, SMR, CN and SLA conceived the idea, and all authors except MU were involved in planning the paper. SLA led writing and editing of the manuscript. CN, JH, and SMR contributed written sections, and all authors were involved in editing the manuscript. SMR oversaw the project as senior author. All authors approved the final version.
Competing interests
JH, SMR, and SV are members of the editorial board for Chiropractic & Manual Therapies but had no involvement in the processing, review, or editorial decision making of this submission and were blinded to the process.
JH has received multiple grants from Danish and international funding sources including the Danish Chiropractic Research Fund. CEC is an editorial board member for JOSPT and the Director of the Center of Excellence in Manual and Manipulative Therapy at Duke University.
DHS is an osteopathic practitioner and educator, serves as executive committee member of the Society for Back Pain Research, and has received consulting fees from Altern Health Ltd.
MU is chief investigator or co-investigator on multiple previous and current research grants from the UK National Institute for Health Research, and is a co-investigator on grants funded by the Australian NHMRC and Norwegian MRC. He was an NIHR Senior Investigator until March 2021. He is a director and shareholder of Clinvivo Ltd that provides electronic data collection for health services research. He receives some salary support from University Hospitals Coventry and Warwickshire. He is a co-investigator on two current and one completed NIHR funded studies that have, or have had, additional support from Stryker Ltd.
SMR has received multiple grants from the Dutch-Belgian Research Institute of Chiropractic (DBRIC), the European Centre for Chiropractic Research and Excellence (ECCRE); serves as the Chair on the Research Commission of the World Federation of Chiropractic (WFC) as well as works as a chiropractor in private practice.
SLA, CN, and ES have no competing interests to declare.
References:
Rřttingen JA, Regmi S, Eide M, Young AJ, Viergever RF, Ardal C, et al.
Mapping of available health research and development data: what’s there,
what’s missing, and what role is there for a global observatory?
Lancet. 2013;382(9900):1286–307.
doi: 10.1016/s0140-6736(13)61046-6.
Chalmers I, Glasziou P.
Avoidable Waste in the production and reporting of Research evidence.
Lancet. 2009;374(9683):86–9.
doi: 10.1097/AOG.0b013e3181c3020d.
Glasziou P, Chalmers I.
Research waste is still a scandal—an essay by Paul Glasziou and Iain Chalmers.
BMJ. 2018;363:k4645.
doi: 10.1136/bmj.k4645.
Ioannidis JPA.
The Mass production of redundant, misleading, and
conflicted systematic reviews and Meta-analyses.
Milbank Q. 2016;94(3):485–514.
doi: 10.1111/1468-0009.12210.
Grudniewicz A, Moher D, Cobey KD, Bryson GL, Cukier S, Allen K, et al.
Predatory journals: no definition, no defence.
Nature. 2019;576:210.
doi: 10.1038/d41586-019-03759-y.
Bartholomew RE.
Science for sale: the rise of predatory journals.
J R Soc Med. 2014;107(10):384–5.
doi: 10.1177/0141076814548526.
Altman DG.
The scandal of poor medical research.
BMJ. 1994;308(6924):283.
doi: 10.1136/bmj.308.6924.283.
Begg C, Cho M, Eastwood S, Horton R, Moher D, Olkin I, et al.
Improving the quality of reporting of randomized controlled trials.
The CONSORT statement.
JAMA. 1996;276(8):637–9.
doi: 10.1001/jama.276.8.637.
Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gřtzsche PC, Ioannidis JPA, et al.
The PRISMA Statement for reporting systematic reviews and Meta-analyses
of studies that evaluate Health Care interventions:
explanation and elaboration.
PLoS Med. 2009;6(7):e1000100.
doi: 10.1371/journal.pmed.1000100.
International Committee of Medical Journal Editors.
Clinical trial registration: a statement from the International
Committee of Medical Journal Editors. 2005.
http://www.icmje.org/news-and-editorials/clin_trial_sep2004.pdf
Accessed June 2023.
Costa LOP, Lin C-WC, Grossi DB, Mancini MC, Swisher AK, Cook C, et al.
Clinical trial registration in physiotherapy journals:
recommendations from the International Society
of Physiotherapy Journal Editors.
J Physiother. 2012;58(4):211–3.
doi: 10.1016/S1836-9553(12)70122-4.
Chan L, Heinemann AW, Roberts J.
Elevating the quality of disability and Rehabilitation Research:
mandatory use of the Reporting guidelines.
Am J Occup Ther. 2014;68(2):127–9.
doi: 10.5014/ajot.2014.682004.
Spence OM, Hong K, Onwuchekwa Uba R, Doshi P.
Availability of study protocols for randomized trials published in
high-impact medical journals: a cross-sectional analysis.
Clin Trails. 2019;17(1):99–105.
doi: 10.1177/1740774519868310.
Alvarez G, Solŕ I, Sitjŕ-Rabert M, Fort-Vanmeerhaeghe A, Gich I, Fernández C, et al.
A methodological review revealed that reporting of trials
in manual therapy has not improved over time.
J Clin Epidemiol. 2020;121:32–44.
doi: 10.1016/j.jclinepi.2020.01.006.
World Health Organization.
Number of grants for biomedical research by funder,
type of grant, duration and recipients (World RePORT).
Available Accessed May 2023.
Ferreira ML, de Luca K, Haile LM, Steinmetz JD, Culbreth GT, Cross M, et al.
Global, Regional, and National Burden of Low Back Pain,
1990–2020,
Its Attributable Risk Factors, and Projections to 2050: A Systematic
Analysis of the Global Burden of Disease Study 2021
Lancet Rheumatology 2023 (May 23); 5 (6): E316-E329
European Commission, Directorate-General for Research Innovation,
Tuyl L, Zinger N, Heide I, Kroneman M et al.
Scoping study on evidence to tackle high-burden under-researched
medical conditions – Discussion paper.
Publications Office of the European Union, 2023. https://data.europa.eu/doi/10.2777/311040
Accessed Nov 2023.
Hurwitz EL,
Epidemiology: Spinal Manipulation Utilization
J Electromyogr Kinesiol. 2012 (Oct); 22 (5): 648–654
Foster NE, Anema JR, Cherkin D, Chou R, Cohen SP, Gross DP, et al.
Prevention and Treatment of Low Back Pain: Evidence,
Challenges, and Promising Directions
Lancet. 2018 (Jun 9); 391 (10137): 2368–2383
Lin I, Wiles L, Waller R, Goucke R, Nagree Y, Gibberd M, et al.
What Does Best Practice Care for Musculoskeletal Pain Look Like?
Eleven Consistent Recommendations From High-quality Clinical
Practice Guidelines: Systematic Review
British J Sports Medicine 2020 (Jan); 54 (2): 79–86
Gevers-Montoro C, Provencher B, Descarreaux M, Ortega de Mues A, Piché M.
Neurophysiological Mechanisms of Chiropractic
Spinal Manipulation for Spine Pain
European Journal of Pain 2021 (Aug); 25 (7): 1429–1448
Bialosky JE, Beneciuk JM, Bishop MD, Coronado RA, Penza CW, Simon CB, et al.
Unraveling the mechanisms of Manual Therapy: modeling an Approach.
J Orthop Sports Phys Ther. 2018;48(1):8–18.
doi: 10.2519/jospt.2018.7476.
Hartvigsen J, Hancock MJ, Kongsted A, Louw Q, Ferreira ML, Genevay S, Hoy D, Karppinen J et al.
What Low Back Pain Is and Why We Need to Pay Attention
Lancet. 2018 (Jun 9); 391 (10137): 2356–2367
This is the second of 4 articles in the remarkable
Lancet Series on Low Back Pain
Becker WC, DeBar LL, Heapy AA, Higgins D, Krein SL, Lisi A, et al.
A Research Agenda for advancing non-pharmacological management of
Chronic Musculoskeletal Pain: findings from a VHA State-of-the-art conference.
J Gen Intern Med. 2018;33(1):11–5
10.1007/s11606-018-4345-6.
Nim CG, Aspinall SL, Cook CE, Corręa LA, Donaldson M, Downie AS, et al.
The effectiveness of spinal manipulative therapy procedures for spine pain:
protocol for a systematic review and network meta-analysis.
Chiropr Man Ther. 2023;31(1):14.
doi: 10.1186/s12998-023-00487-z.
Rubinstein SM, de Zoete A, van Middelkoop M, Assendelft WJJ, de Boer MR, van Tulder MW.
Benefits and Harms of Spinal Manipulative Therapy for the Treatment
of Chronic Low Back Pain: Systematic Review and
Meta-analysis of Randomised Controlled Trials
British Medical Journal 2019 (Mar 13); 364: 1689
Gross A, Langevin P, Burnie SJ, Bédard-Brochu MS, Empey B, Dugas E, et al.
Manipulation and mobilisation for neck pain contrasted against an inactive control or another active treatment.
Cochrane Database Syst Rev.2015;910.1002/14651858.CD004249.pub4.
Molina-Álvarez M, Arribas-Romano A, Rodríguez-Rivera C, García MM, et al.
Manual therapy effect in placebo-controlled trials:
a systematic review and Meta-analysis.
Int J Environ Res Public Health. 2022;19(21):14021.
doi: 10.3390/ijerph192114021.
Paige NM, Miake-Lye IM, Booth MS, Beroes JM, Mardian AS, Dougherty P, et al.
Association of Spinal Manipulative Therapy With Clinical Benefit
and
Harm for Acute Low Back Pain: Systematic Review and Meta-analysis
JAMA. 2017 (Apr 11); 317 (14): 1451–1460
Minnucci S, Innocenti T, Salvioli S, Giagio S, Yousif MS, Riganelli F, et al.
Benefits and Harms of spinal manipulative therapy for treating recent
and persistent nonspecific Neck Pain: a systematic review with Meta-analysis.
J Orthop Sports Phys Ther. 2023;53(9):510–28.
doi: 10.2519/jospt.2023.11708.
Lavazza C, Galli M, Abenavoli A, Maggiani A.
Sham treatment effects in manual therapy trials on back pain
patients: a systematic review and pairwise meta-analysis.
BMJ Open. 2021;11(5):e045106.
doi: 10.1136/bmjopen-2020-045106.
Hohenschurz-Schmidt D, Draper-Rodi J, Vase L, Scott W, McGregor A, Soliman N, et al.
Blinding and sham control methods in trials of physical, psychological,
and self-management interventions for pain (article II):
a meta-analysis relating methods to trial results.
Pain. 2023;164(3):509–33.
doi: 10.1097/j.pain.0000000000002730.
Puhl AA, Reinhart CJ, Doan JB, Vernon H.
The Quality of Placebos used in Randomized, Controlled Trials of
Lumbar and Pelvic Joint Thrust Manipulation - A Systematic Review
Spine J. 2017 (Mar); 17 (3): 445–456
Pool J, Maissan F, de Waele N, Wittink H, Ostelo R. Completeness of the description of manipulation and mobilisation techniques in randomized controlled trials in neck pain; a review using the TiDieR checklist. Musculoskelet Sci Prac. 2020;45:102098. doi: 10.1016/j.msksp.2019.102098.
Moncher FJ, Prinz RJ. Treatment fidelity in outcome studies. Clin Psychol Rev. 1991;11(3):247–66. doi: 10.1016/0272-7358(91)90103-2.
Borrelli B, Sepinwall D, Ernst D, Bellg AJ, Czajkowski S, Breger R, et al. A new tool to assess treatment fidelity and evaluation of treatment fidelity across 10 years of health behavior research. J Consult Clin Psychol. 2005;73(5):852–60. doi: 10.1037/0022-006X.73.5.852.
An M, Dusing SC, Harbourne RT, Sheridan SM, Consortium S-P. What really works in intervention? Using Fidelity measures to support optimal outcomes. Phys Ther. 2020;100(5):757–65. doi: 10.1093/ptj/pzaa006.
McGee D, Lorencatto F, Matvienko-Sikar K, Toomey E. Surveying knowledge, practice and attitudes towards intervention fidelity within trials of complex healthcare interventions. Trials. 2018;19(1):504. doi: 10.1186/s13063-018-2838-6.
Karas S, Plankis L. Consideration of treatment fidelity to improve manual therapy research. J Man Manip Ther. 2016;24(4):233–7. doi: 10.1080/10669817.2015.1135555.
Rubinstein SM, van Eekelen R, Oosterhuis T, de Boer MR, Ostelo RW, van Tulder MW. The risk of bias and sample size of trials of spinal manipulative therapy for low back and neck pain: analysis and recommendations. J Manipulative Physiol Ther. 2014;37(8):523–41. doi: 10.1016/j.jmpt.2014.07.007.
Krekoukias G, Gelalis ID, Xenakis T, Gioftsos G, Dimitriadis Z, Sakellari V. Spinal mobilization vs conventional physiotherapy in the management of chronic low back pain due to spinal disk degeneration: a randomized controlled trial. J Man Manip Ther. 2017;25(2):66–73. doi: 10.1080/10669817.2016.1184435.
Samir SM, ZakY LA, Soliman MO. Mulligan versus Maitland mobilizations in patients with chronic low back dysfunction. Int J Pharm Tech Res. 2016;9(6):92–9. [Google Scholar]
Sarker KK, Mohanty U, Sethi J. Effect of spinal manipulation on postural instability in patients with non specific low back pain. Int J Pharm Bio Sci. 2017;7(3):992–9. [Google Scholar]
Ulger O, Demirel A, Oz M, Tamer S.
The Efficacy of Manual Therapy and Exercise for Treating
Non-specific Neck Pain: A Systematic Review
J Back Musculoskelet Rehabil 2017 (Nov 6); 30 (6): 1149-1169
Waqqar S, Shakil-ur-Rehman S, Ahmad S. McKenzie treatment versus mulligan sustained natural apophyseal glides for chronic mechanical low back pain. Pak J Med Sci. 2016;32(2):476–9. doi: 10.12669/pjms.322.9127.
Bond BM, Kinslow CD, Yoder AW, Liu W. Effect of spinal manipulative therapy on mechanical pain sensitivity in patients with chronic nonspecific low back pain: a pilot randomized, controlled trial. J Man Manip Ther. 2020;28(1):15–27. doi: 10.1080/10669817.2019.1572986.
Thabane L, Ma J, Chu R, Cheng J, Ismaila A, Rios LP, et al. A tutorial on pilot studies: the what, why and how. BMC Med Res Methodol. 2010;10:1. doi: 10.1186/1471-2288-10-1.
Dettori JR, Norvell DC, Chapman JR. Fixed-effect vs Random-effects models for Meta-Analysis: 3 points to consider. Global Spine J. 2022;12(7):1624–6. doi: 10.1177/21925682221110527.
Gyer G, Michael J, Inklebarger J, Tedla JS.
Spinal Manipulation Therapy: Is It All About the Brain?
A Current Review of the Neurophysiological
Effects of Manipulation
J Integrative Medicine 2019 (Sep); 17 (5): 328–337
Lima CR, Martins DF, Reed WR.
Physiological Responses Induced by Manual Therapy
in Animal Models: A Scoping Review
Frontiers in Neuroscience 2020 (May 8); 14: 430
Gyer G, Michael J, Inklebarger J, Ibne Alam I. Effects of biomechanical parameters of spinal manipulation: a critical literature review. J Integr Med. 2022;20(1):4–12. doi: 10.1016/j.joim.2021.10.002.
Wichman C, Smith LM, Yu F. A framework for clinical and translational research in the era of rigor and reproducibility. J Clin Transl Sci. 2020;5(1):e31. doi: 10.1017/cts.2020.523.
Aspinall SL, Leboeuf-Yde C, Etherington SJ, Walker BF. Manipulation-induced hypoalgesia in musculoskeletal pain populations: a systematic critical review and meta-analysis. Chiropr Man Ther. 2019;27(7). 10.1186/s12998-018-0226-7.
Millan M, Leboeuf-Yde C, Budgell B, Amorim M.
The Effect of Spinal Manipulative Therapy on Experimentally Induced Pain: A Systematic Literature Review
Chiropractic & Manual Therapies 2012 (Aug 10); 20 (1): 26
Honoré M, Leboeuf-Yde C, Gagey O. The regional effect of spinal manipulation on the pressure pain threshold in asymptomatic subjects: a systematic literature review. Chiropr Man Ther. 2018;26(1):11. doi: 10.1186/s12998-018-0181-3.
Coronado RA, Gay CW, Bialosky JE, Carnaby GD, Bishop MD, George SZ.
Changes in Pain Sensitivity Following Spinal Manipulation:
A Systematic Review and Meta-analysis
J Electromyogr Kinesiol. 2012 (Oct); 22 (5): 752–767
Rodgers LJ, Bialosky JE, Minick SA, Coronado RA. An overview of systematic reviews examining the quantitative sensory testing-derived hypoalgesic effects of manual therapy for musculoskeletal pain. J Man Manip Ther. 2023;1–18. 10.1080/10669817.2023.2267954.
Skyba DA, Radhakrishnan R, Rohlwing JJ, Wright A, Sluka KA.
Joint Manipulation Reduces Hyperalgesia By Activation of Monoamine
Receptors But Not Opioid or GABA Receptors in the Spinal Cord
Pain. 2003 (Nov); 106 (1-2): 159–168
Nim CG, Aspinall SL, Weibel R, Steenfelt MG, O’Neill S. Pressure pain thresholds in a real-world chiropractic setting: topography, changes after treatment, and clinical relevance? Chiropr Man Ther. 2022;30(1):25. doi: 10.1186/s12998-022-00436-2.
Aspinall SL, Leboeuf-Yde C, Etherington SJ, Walker BF. Changes in pressure pain threshold and temporal summation in rapid responders and non-rapid responders after lumbar spinal manipulation and sham: a secondary analysis in adults with low back pain. Musculoskelet Sci Prac. 2020;47:102137. doi: 10.1016/j.msksp.2020.102137.
Nim CG, Kawchuk GN, Schiřttz-Christensen B, O’Neill S. The effect on clinical outcomes when targeting spinal manipulation at stiffness or pain sensitivity: a randomized trial. Sci Rep. 2020;10(1):14615. doi: 10.1038/s41598-020-71557-y.
Vo T-T, Superchi C, Boutron I, Vansteelandt S. The conduct and reporting of mediation analysis in recently published randomized controlled trials: results from a methodological systematic review. J Clin Epidemiol. 2020;117:78–88. doi: 10.1016/j.jclinepi.2019.10.001.
Baron RM, Kenny DA. The moderator–mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. J Pers Soc Psychol. 1986;51(6):1173–82. doi: 10.1037/0022-3514.51.6.1173.
Burns JW, Jensen MP, Gerhart J, Thorn BE, Lillis TA, Carmody J, et al. Cognitive therapy, mindfulness-based stress reduction, and behavior therapy for people with chronic low back pain: a comparative mechanisms study. J Consult Clin Psychol. 2023;91(3):171–87. doi: 10.1037/ccp0000801.
Paz TSR, Rodrigues PTV, Silva BM, de Sá Ferreira A, Nogueira LAC. Mediation Analysis in Manual Therapy Research. J Chiropr Med. 2023;22(1):35–44. doi: 10.1016/j.jcm.2022.04.007.
Pincus T, Miles C, Froud R, Underwood M, Carnes D, Taylor SJC. Methodological criteria for the assessment of moderators in systematic reviews of randomised controlled trials: a consensus study. BMC Med Res Methodol. 2011;11(1):14. doi: 10.1186/1471-2288-11-14.
Rijnhart JJM, Twisk JWR, Valente MJ, Heymans MW. Time lags and time interactions in mixed effects models impacted longitudinal mediation effect estimates. J Clin Epidemiol. 2022;151:143–50. doi: 10.1016/j.jclinepi.2022.07.004.
Lohman EB, Pacheco GR, Gharibvand L, Daher N, Devore K, Bains G, et al. The immediate effects of cervical spine manipulation on pain and biochemical markers in females with acute non-specific mechanical neck pain: a randomized clinical trial. J Man Manip Ther. 2019;27(4):186–96. doi: 10.1080/10669817.2018.1553696.
Valera-Calero A, Lluch Girbés E, Gallego-Izquierdo T, Malfliet A, Pecos-Martín D. Endocrine response after cervical manipulation and mobilization in people with chronic mechanical neck pain: a randomized controlled trial. Eur J Phys Rehabil Med. 2019;55(6):792–805. doi: 10.23736/s1973-9087.19.05475-3.
Fryer G, Pearce AJ. The Effect of Lumbosacral Manipulation on Corticospinal and spinal Reflex excitability on asymptomatic participants. J Manipulative Physiol Ther. 2012;35(2):86–93. doi: 10.1016/j.jmpt.2011.09.010.
Sparks CL, Liu WC, Cleland JA, Kelly JP, Dyer SJ, Szetela KM, et al. Functional magnetic resonance imaging of cerebral hemodynamic responses to Pain following thoracic thrust manipulation in individuals with Neck Pain: a Randomized Trial. J Manipulative Physiol Ther. 2017;40(9):625–34. doi: 10.1016/j.jmpt.2017.07.010.
Honoré M, Leboeuf-Yde C, Gagey O, Wedderkopp N. How big is the effect of spinal manipulation on the pressure pain threshold and for how long does it last? – secondary analysis of data from a systematic review. Chiropr Man Ther. 2019;27(1):22. doi: 10.1186/s12998-019-0240-4.
Kovanur-Sampath K, Mani R, Cotter J, Gisselman AS, Tumilty S. Changes in biochemical markers following spinal manipulation-a systematic review and meta-analysis. Musculoskelet Sci Prac. 2017;29:120–31. doi: 10.1016/j.msksp.2017.04.004.
Araujo FX, Ferreira GE, Angellos RF, Stieven FF, Plentz RDM, Silva MF. Autonomic effects of spinal manipulative therapy: systematic review of Randomized controlled trials. J Manipulative Physiol Ther. 2019;42(8):623–34. doi: 10.1016/j.jmpt.2018.12.005.
Fisher AR, Bacon CJ, Mannion JVH. The effect of cervical spine manipulation on postural sway in patients with nonspecific Neck Pain. J Manipulative Physiol Ther. 2015;38(1):65–73. doi: 10.1016/j.jmpt.2014.10.014.
Niazi IK, Kamavuako EN, Holt K, Janjua TAM, Kumari N, Amjad I, et al. The effect of spinal manipulation on the electrophysiological and metabolic properties of the Tibialis Anterior muscle. Healthcare. 2020;8(4):548. doi: 10.3390/healthcare8040548.
Gay CW, Robinson ME, George SZ, Perlstein WM, Bishop MD. Immediate Changes after Manual Therapy in resting-state functional connectivity as measured by Functional Magnetic Resonance Imaging in participants with Induced Low Back Pain. J Manipulative Physiol Ther. 2014;37(9):614–27. doi: 10.1016/j.jmpt.2014.09.001.
Karason AB, Drysdale IP. Somatovisceral response following osteopathic HVLAT: a pilot study on the effect of unilateral lumbosacral high-velocity low-amplitude thrust technique on the cutaneous blood flow in the lower limb. J Manipulative Physiol Ther. 2003;26(4):220–5. doi: 10.1016/s0161-4754(02)54110-5.
Fernández-de-las-Peńas C, Pérez-de-Heredia M, Brea-Rivero M, Miangolarra-Page JC.
Immediate Effects on Pressure Pain Threshold Following a
Single Cervical Spine Manipulation in Healthy Subjects
J Orthop Sports Phys Ther. 2007 (Jun); 37 (6): 325–329
O’Neill S, Odegaard-Olsen O, Sovde B.
The Effect of Spinal Manipulation on Deep Experimental
Muscle Pain in Healthy Volunteers
Chiropractic & Manual Therapies 2015 (Sep 7); 23: 25
Newell D, Lothe LR, Raven TJL. Contextually aided recovery (CARe): a scientific theory for innate healing. Chiropr Man Ther. 2017;25:6. doi: 10.1186/s12998-017-0137-z.
Hafliethadottir SH, Juhl CB, Nielsen SM, Henriksen M, Harris IA, Bliddal H, et al. Placebo response and effect in randomized clinical trials: meta-research with focus on contextual effects. Trials. 2021;22(1):493. doi: 10.1186/s13063-021-05454-8.
Menke JM. Do manual therapies help low back pain? A comparative effectiveness meta-analysis. Spine (Phila Pa 1976) 2014;39(7):E463–72. doi: 10.1097/BRS.0000000000000230.
Kawchuk GN, Haugen R, Fritz J. A true blind for subjects who receive spinal manipulation therapy. Arch Phys Med Rehabil. 2009;90(2):366–8. doi: 10.1016/j.apmr.2008.08.213.
Hohenschurz-Schmidt D, Vase L, Scott W, Annoni M, Ajayi OK, Barth J, et al. Recommendations for the development, implementation, and reporting of control interventions in efficacy and mechanistic trials of physical, psychological, and self-management therapies: the CoPPS Statement. BMJ. 2023;381:e072108. doi: 10.1136/bmj-2022-072108.
Fortunato S, Bergstrom CT, Börner K, Evans JA, Helbing D, Milojevi? S, et al. Sci Sci Sci. 2018;359(6379). 10.1126/science.aao0185.
Disis ML, Slattery JT. The Road we must take: Multidisciplinary Team Science. Sci Transl Med. 2010;2(22):cm229–9. doi: 10.1126/scitranslmed.3000421.
Larivičre V, Haustein S, Börner K. Long-Distance Interdisciplinarity leads to higher scientific impact. PLoS ONE. 2015;10(3):e0122565. doi: 10.1371/journal.pone.0122565.
Arumugam A, Phillips LR, Moore A, Kumaran SD, Sampath KK, Migliorini F, et al. Patient and public involvement in research: a review of practical resources for young investigators. BMC Rheumatol. 2023;7(1):2. doi: 10.1186/s41927-023-00327-w.
Hay-Smith EJC, Brown M, Anderson L, Treharne GJ. Once a clinician, always a clinician: a systematic review to develop a typology of clinician-researcher dual-role experiences in health research with patient-participants. BMC Med Res Methodol. 2016;16(1):95. doi: 10.1186/s12874-016-0203-6.
Chalmers I, Bracken MB, Djulbegovic B, Garattini S, Grant J, Gülmezoglu AM, et al. How to increase value and reduce waste when research priorities are set. Lancet. 2014;383(9912):156–65. doi: 10.1016/S0140-6736(13)62229-1.
Salman RA-S, Beller E, Kagan J, Hemminki E, Phillips RS, Savulescu J, et al. Increasing value and reducing waste in biomedical research regulation and management. Lancet. 2014;383(9912):176–85. doi: 10.1016/S0140-6736(13)62297-7.
Chan A-W, Song F, Vickers A, Jefferson T, Dickersin K, Gřtzsche PC, et al. Increasing value and reducing waste: addressing inaccessible research. Lancet. 2014;383(9913):257–66. doi: 10.1016/S0140-6736(13)62296-5.
Glasziou P, Altman DG, Bossuyt P, Boutron I, Clarke M, Julious S, et al. Reducing waste from incomplete or unusable reports of biomedical research. Lancet. 2014;383(9913):267–76. doi: 10.1016/S0140-6736(13)62228-X.
Ioannidis JPA, Greenland S, Hlatky MA, Khoury MJ, Macleod MR, Moher D, et al. Increasing value and reducing waste in research design, conduct, and analysis. Lancet. 2014;383(9912):166–75. doi: 10.1016/S0140-6736(13)62227-8.
EQUATOR Network [Internet]. https://www.equator-network.org/. Accessed Nov 2023.
Schulz KF, Altman DG, Moher D, the CG CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. BMC Med. 2010;8(1):18. doi: 10.1186/1741-7015-8-18.
Groeneweg R, Rubinstein SM, Oostendorp RAB, Ostelo RWJG, van Tulder MW. Guideline for reporting interventions on spinal manipulative therapy: Consensus on interventions reporting Criteria list for spinal manipulative therapy (CIRCLe SMT) J Manipulative Physiol Ther. 2017;40(2):61–70. doi: 10.1016/j.jmpt.2016.10.013.
Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. PLoS Med. 2021;18(3):e1003583. doi: 10.1371/journal.pmed.1003583.
Sterne JAC, Savovi? J, Page MJ, Elbers RG, Blencowe NS, Boutron I, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366:l4898. doi: 10.1136/bmj.l4898.
Sterne JA, Hernán MA, Reeves BC, Savovi? J, Berkman ND, Viswanathan M, et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ. 2016;355:i4919. doi: 10.1136/bmj.i4919.
Cochrane Handbook for Systematic Reviews of Interventions: Cochrane. 2023 [cited Jan 2024. www.training.cochrane.org/handbook.
Hohenschurz-Schmidt DJ, Cherkin D, Rice ASC, Dworkin RH, Turk DC, McDermott MP, et al. Research objectives and general considerations for pragmatic clinical trials of pain treatments: IMMPACT statement. Pain. 2023;164(7):1457–72. doi: 10.1097/j.pain.0000000000002888.
Return to CHIROPRACTIC RESEARCH
Since 6-19-2024
|